Group items tagged

US-based BioMarin Pharmaceutical has selected a new drug development candidate, BMN 250, for the treatment of Sanfilippo B syndrome or Mucopolysaccharidosis type IIIB (MPS IIIB).

Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has expanded its relationship by entering into a master clinical trial agreement with GRU Cancer Center at Georgia Regents University to conduct four Phase I/II clinical trials.

US-based developer of new immunotherapeutics, including a portfolio of checkpoint modulators, anti-cancer vaccines and adjuvants, Agenus has completed the acquisition of Switzerland-based biopharmaceutical firm 4-Antibody.

Published 25 February 2014 Cambridge Healthtech Associates (CHA) has announced a new program to accelerate innovation in life sciences and health care. Announcing the launch of the first-ever tool in life sciences and health care to evaluate and rank new technologies and services via an end-user process.

PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).

Novartis has acquired CoStim Pharmaceuticals, an immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.

PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.

PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).

Novavax has announced the execution of a contract modification to extend the base period of performance of its current contract with the US Department of Health and Human Services, Biomedical Advanced Research and Development Authority

GSK submits sNDA for Promacta to FDA for severe aplastic anaemia treatment

US-based Edison Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for its lead drug EPI-743 to treat patients with Friedreich's ataxia.

Teva Pharmaceutical Industries has launched the generic equivalent to Xeloda tablets, 150mg and 500mg, in the US.

Scottish biotechnology firm TC BioPharm (TCB) and Japanese immuno-cell therapy company Medinet have entered into a strategic collaboration to develop a new treatment for different types of cancer.

Israel-based clinical-stage pharmaceutical firm Oramed Pharmaceuticals has received its third patent in Australia for oral administration of exenatide from the Australian government's patent office 'IP Australia'.

Supple contains glucosamine, chondroitin sulfate, vitamins C, D, E and a number of the B vitamins (B3, B5, B6 and B12), calcium and magnesium, and a plant extract called rebaudioside-A.It contains 115 mgs. of sodium per serving so people with high blood pressure who need to monitor their sodium levels should take that into account when using Supple.

Animal Flex is designed as a core or "foundational" supplement, and contains required nutrients that your body needs on a daily basis in order to support healthy joint function and heavy lifting. Flex can be taken year round without cycling off. It can be stacked with the other Animal supplements.

Zyflamend is a dietary supplement that contains extracts of rosemary, turmeric, ginger, holy basil, green tea, hu zhang, Chinese goldthread, barberry, oregano, and Baikal skullcap. The individual components of Zyflamend have anti-inflammatory and possible anti-carcinogenic properties.

With over eight million units oversubscribed, Arthro-7 is clinically established to alleviate joint discomfort, promote joint quality, rejuvenate joint tissue, and nourish joint gristle. For over a decade, the bone and joint supplement Arthro-7 has helped thousands of individuals notice relief from joint discomfort and support their quality. A recently printed scientific study confirms that Arthro-7 is clinically effective in relieving joint discomfort and stiffness, and promoting quality.

Animal Flex is designed as a core or "foundational" supplement, and contains required nutrients that your body needs on a daily basis in order to support healthy joint function and heavy lifting. Flex can be taken year round without cycling off. It can be stacked with the other Animal supplements.

Advil is a nonsteroidal anti-inflammatory drug(NSAID). It works by reducing hormones that cause inflammation and pain within the body. nonsteroidal anti-inflammatory drug is used to reduce fever and treat pain or inflammation caused by several conditions like headache, toothache, back pain, arthritis, discharge cramps, or minor injury. advil can also be used for functions ex-directory in this medication guide.